Page last updated: 2024-12-08
roseofungin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
roseofungin: polyene antibiotic produced by a Streptomyces strain; Russian drug [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 197137 |
MeSH ID | M0053678 |
Synonyms (4)
Synonym |
---|
roseofungin |
12687-98-8 |
DTXSID101106214 |
14,16,18,20,24,26-hexahydroxy-3-methyl-36-(1-methylethyl)oxacyclohexatriaconta-3,5,7,9,11,13-pentaene-2,22,28-trione |
Research Excerpts
Overview
Roseofungin is a pentaene antibiotic of the subgroup of carbonyl conjugated pentaenes.
Excerpt | Reference | Relevance |
---|---|---|
"Roseofungin is a pentaene antibiotic of the subgroup of carbonyl conjugated pentaenes. " | ( [Structure of the pentaene antibiotic roseofungin]. Daurenbekova, AS; Iakovlev, AA; Morgunova, AF; Shenin, IuD; Vetlugina, LA, 1986) | 1.98 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (70.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.04
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.04) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |